Concise review: Human cell engineering: Cellular reprogramming and genome editing

Stem Cells

Volumn 30, Issue 1, 2012, Pages 75-81

  Mali, Prashant ^a,b   Cheng, Linzhao ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Disease modeling; Gene targeting; Gene therapy; Genome editing; Genome engineering; Human cell reprogramming; Pluripotent stem cells

Indexed keywords

ADENOVIRUS; BLASTOCYST; CELL DIFFERENTIATION; CELL ENGINEERING; CELL FUSION; CELL NUCLEUS TRANSPLANTATION; CELLULAR REPROGRAMMING; EMBRYONIC STEM CELL; FERTILIZATION; FUTUROLOGY; GENE TARGETING; GENE THERAPY; GENETIC DISORDER; GENOME EDITING; HUMAN; PROCEDURES CONCERNING CELLS; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION; TRANSPOSON;

CELL DIFFERENTIATION; CELL ENGINEERING; EPIGENESIS, GENETIC; GENOME; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; STEM CELLS;

MAMMALIA;

EID: 84855398949     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.735     Document Type: Review

References (64)

1. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008;132:661-680. (Pubitemid 351260059)
2. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007;447:425-432. (Pubitemid 46816749)
3. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009;136:509-523.
4. Wilmut I, Schnieke AE, McWhir J et al. Viable offspring derived from fetal and adult mammalian cells. Cloning Stem Cells 2007;9:3-7.
5. Cowan CA, Atienza J, Melton DA et al. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005;309:1369-1373. (Pubitemid 41209363)
6. Mali P, Cheng L. Re-programming somatic cells without fusion or ethical confusion. Regen Med 2006;1:837-840.
7. Hansis C, Barreto G, Maltry N et al. Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr Biol 2004;14:1475-1480. (Pubitemid 39123745)
8. Taranger CK, Noer A, Sorensen AL et al. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Cell Biol 2005;16:5719.
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
10. Maherali N, Sridharan R, Xie W et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007;1:55-70.
11. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448: 318-324. (Pubitemid 47080337)
12. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317. (Pubitemid 47080336)
13. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
14. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
15. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
16. Mali P, Ye Z, Hammond HH et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 2008;26:1998-2005.
17. Mali P, Chou BK, Yen J et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 2010;28:713-720.
18. Huangfu D, Osafune K, Maehr R et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008;26:1269-1275.
19. Shi Y, Desponts C, Do JT et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008;3:568-574.
20. Lin T, Ambasudhan R, Yuan X et al. A chemical platform for improved induction of human iPSCs. Nat Methods 2009;6:805-808.
21. Yoshida Y, Takahashi K, Okita K et al. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009;5:237-241.
22. Subramanyam D, Lamouille S, Judson RL et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011;29:443-448.
23. Anokye-Danso F, Trivedi CM, Juhr D et al. Highly Efficient miRNAmediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011;8:376-388.
24. Cavazzana-Calvo M, Payen E, Negre O et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010;467:318-322.
25. Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302:415.
26. Howe SJ, Mansour MR, Schwarzwaelder K et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008;118:3143.
27. Ott MG, Schmidt M, Schwarzwaelder K et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 Or SETBP1. Nat Med 2006;12:401-409.
28. Schröder ARW, Shinn P, Chen H et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002;110:521-529. (Pubitemid 35232295)
29. Okita K, Nakagawa M, Hyenjong H et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008;322:949.
30. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-384.
31. Kim D, Kim CH, Moon JI et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-476.
32. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.
33. Marchetto MC, Yeo GW, Kainohana O et al. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009;4:e7076.
34. Fusaki N, Ban H, Nishiyama A et al. Efficient induction of transgenefree human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009;85:348-362.
35. Jia F, Wilson KD, Sun N et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010;7:197-199.
36. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010;7:618-630.
37. Chou BK, Mali P, Huang X et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 2011; 518-529.
38. Hu K, Yu J, Suknuntha K, Tian S et al. Efficient generation of transgene- free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011;117: e109-e119.
39. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145.
40. Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 1996;93:1156-1160. (Pubitemid 26052857)
41. Porteus MH, Baltimore D. Chimeric nucleases stimulate gene targeting in human cells. Science 2003;300:763. (Pubitemid 36532103)
42. Zou J, Maeder ML, Mali P et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009;5:97-110.
43. Hockemeyer D, Soldner F, Beard C et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 2009;27:851-857.
44. Zou J, Sweeney CL, Chou BK et al. Oxidase deficient neutrophils from X-linked chronic granulomatous disease iPS cells: Functional correction by zinc finger nuclease mediated safe harbor targeting. Blood 2011;117:5561-5572.
45. Soldner F, Laganiere J, Cheng AW et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 2011;146:318-331.
46. Zou J, Mali P, Huang X et al. Site-specific gene correction of a point mutation in human iPS cells derived from sickle cell disease patient. Blood 10.1182/blood-2011-02-335554.
47. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010;467:285-290.
48. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010;28:848-855.
49. Bar-Nur O, Russ HA, Efrat S et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 2011;9:17-23.
50. Ohm JE, Mali P, Van Neste L et al. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Res 2010;70:7662-7673.
51. Stadtfeld M, Apostolou E, Akutsu H et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010;465:175-181.
52. Liu L, Luo GZ, Yang W et al. Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J Biol Chem 2010;285:19483-90.
53. Christian M, Cermak T, Doyle EL et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 2010;186:757.
54. Miller JC, Tan S, Qiao G et al. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 2011;29:143-148.
55. Mitsui K, Suzuki K, Aizawa E et al. Gene targeting in human pluripotent stem cells with adeno-associated virus vectors. Biochem Biophys Res Commun 2009;388:711-717.
56. Khan IF, Hirata RK, Wang PR et al. Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol Ther 2010;18: 1192-1199.
57. Suzuki K, Mitsui K, Aizawa E et al. Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors. Proc Natl Acad Sci USA. 2008; 105:13781.
58. Song H, Chung SK, Xu Y. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 2010;6:80-89.
59. Spence JR, Mayhew CN, Rankin SA et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011;470:105-109.
60. Swistowski A, Peng J, Liu Q et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 2010;28:1893-1904.
61. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
62. Xie H, Ye M, Feng R et al. Stepwise reprogramming of B cells into macrophages. Cell 2004;117:663-676. (Pubitemid 38692531)
63. Vierbuchen T, Ostermeier A, Pang ZP et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463: 1035-1041.
64. Szabo E, Rampalli S, Risueno RM et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010;468:521-526.